![MaaT Pharma Launches a Global Offering of approximately 18 Million Euros](https://www.seventure.fr/wp-content/uploads/2024/05/10_104270789-150x150-4.jpg)
14 May 2024
MaaT Pharma Launches a Global Offering of approximately 18 Million Euros
MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotech company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to...